科研速览 · Science Skim继续刷下去 · Keep skimming →
◇ bioRxiv2026-09-04· bioinformatics

When DL-Based Prescreening Meets Synthon-Based Docking: Target-Adapting PharmacoNet via MEL-Steered Correction

W. Liu, Y. Hong, T. Ku, W. Lee, E. Nguyen, A. Xu, V. Katritch

原始摘要(英文原文)· Original abstract
As chemical libraries expand into the trillions of molecules, Virtual SYNthon Hierarchical Enumeration Screening (V-SYNTHES) has emerged as a leading strategy for making gigascale virtual screening computationally tractable. In V-SYNTHES, a Minimal Enumeration Library (MEL) of chemical fragments is docked against a target first, and only the top-scoring fragments are expanded into full ligands for large-scale docking. However, among the large number of comparably well-docked fragments, only a small fraction can be expanded under a fixed docking budget, leaving most similarly promising fragments unexplored. General-purpose prescreening tools can be adopted to address this constraint, reallocating the same docking budget across a larger pool of fragments' enumerated full ligands by their proxy score. However, such tools are applied without accounting for target-specific pocket environments. One such method, PharmacoNet, predicts interaction hotspots from a protein structure and ranks candidates via graph matching against a fixed set of interaction-type weights. We recognize that V-SYNTHES's initial fragment-docking step, ordinarily used only for selection of best fragments for expansion, already reveals which of these hotspots and interaction types a given pocket actually favors, and we can recover this signal to fine-tune PharmacoNet accordingly. We introduce MEL-Steered PharmacoNet, a parameter-efficient adaptation framework that specializes PharmacoNet to a given target through two composable mechanisms: (i) empirical density-map steering of predicted pharmacophore hotspots, and (ii) empirical fine-tuning of interaction-type scoring weights. Across three structurally distinct GPCR targets (CB2, GPR91, 5-HT2AR), MEL-Steered PharmacoNet achieves substantial enrichment factor (EF100) gains over a random baseline, and improves EF100 over PharmacoNet by 8.94x, 6.87x, and 1.69x, respectively. The fitted per-target weights further reveal distinct, chemically interpretable interaction profiles that PharmacoNet's generic fixed weights fail to capture. These results show that fragment-docking data already generated by the standard V-SYNTHES pipeline can adapt a general-purpose pharmacophore prescreening method to an individual target, significantly improving its performance while retaining its ultra-fast screening ability, with no additional experimental data or model retraining.
读原文 · Read the paper ↗

AI 追问PRO

登录后使用 AI 追问

讨论区

登录后参与讨论

相关论文 · Related

When DL-Based Prescreening Meets Synthon-Based Docking: Target-Adapting PharmacoNet via MEL-Steered Correction — 科研速览 Science Skim